{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:33:31Z","timestamp":1760243611170,"version":"build-2065373602"},"reference-count":50,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2013,10,22]],"date-time":"2013-10-22T00:00:00Z","timestamp":1382400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The common PNPLA3 (adiponutrin) variant, p.I148M, was identified as a genetic determinant of liver fibrosis. Since the expression of PNPLA3 is induced by sterol regulatory element binding protein 1c (SREBP1c), we investigate two common SREBP1c variants (rs2297508 and rs11868035) for their association with liver stiffness. In  899 individuals (aged 17\u201383 years, 547 males) with chronic liver diseases, hepatic fibrosis was non-invasively phenotyped by transient elastography (TE). The SREBP1c single nucleotide polymorphisms (SNPs) were genotyped using PCR-based assays with 5'-nuclease and fluorescence detection. The SREBP1c rs11868035 variant affected liver fibrosis significantly (p = 0.029): median TE levels were 7.2, 6.6 and 6.0 kPa in carriers of (TT)  (n = 421), (CT) (n = 384) and (CC) (n = 87) genotypes, respectively. Overall, the SREBP1c SNP was associated with low TE levels (5.0\u20138.0 kPa). Carriers of both PNPLA3 and SREBP1c risk genotypes displayed significantly (p = 0.005) higher median liver stiffness, as compared to patients carrying none of these variants. The common SREBP1c variant may affect early stages of liver fibrosis. Our study supports a role of the SREBP1c-PNPLA3 pathway as a \u201cdisease module\u201d that promotes hepatic fibrogenesis.<\/jats:p>","DOI":"10.3390\/ijms141021153","type":"journal-article","created":{"date-parts":[[2013,10,23]],"date-time":"2013-10-23T07:45:42Z","timestamp":1382514342000},"page":"21153-21166","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Identification of Combined Genetic Determinants of Liver Stiffness within the SREBP1c-PNPLA3 Pathway"],"prefix":"10.3390","volume":"14","author":[{"given":"Marcin","family":"Krawczyk","sequence":"first","affiliation":[{"name":"Department of Medicine II, Saarland University Medical Center, Homburg 66421, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Gr\u00fcnhage","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Saarland University Medical Center, Homburg 66421, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Lammert","sequence":"additional","affiliation":[{"name":"Department of Medicine II, Saarland University Medical Center, Homburg 66421, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2013,10,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nrgastro.2010.170","article-title":"Genome-wide association studies and genetic risk assessment of liver diseases","volume":"7","author":"Krawczyk","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000071293","article-title":"Bleeding complications after percutaneous liver biopsy. An analysis of risk factors","volume":"67","author":"Terjung","year":"2003","journal-title":"Digestion"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1092 human genomes","volume":"491","author":"Abecasis","year":"2012","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jhep.2010.10.042","article-title":"Variant adiponutrin (PNPLA3) represents a common fibrosis risk gene: Non-invasive elastography-based study in chronic liver disease","volume":"55","author":"Krawczyk","year":"2011","journal-title":"J. Hepatol"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.2337\/db09-0279","article-title":"Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene","volume":"58","author":"Kantartzis","year":"2009","journal-title":"Diabetes"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s00125-009-1285-z","article-title":"A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans","volume":"52","author":"Kotronen","year":"2009","journal-title":"Diabetologia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1194\/jlr.P900013-JLR200","article-title":"A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity","volume":"50","author":"Sookoian","year":"2009","journal-title":"J. Lipid. Res"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ijo.2009.216","article-title":"Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent","volume":"34","author":"Romeo","year":"2010","journal-title":"Int. J. Obes. (Lond.)"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep.23823","article-title":"I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease","volume":"52","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1478-3231.2010.02444.x","article-title":"Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: The insulin resistance atherosclerosis family study","volume":"31","author":"Wagenknecht","year":"2011","journal-title":"Liver. Int"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng.488","article-title":"Variant in PNPLA3 is associated with alcoholic liver disease","volume":"42","author":"Tian","year":"2010","journal-title":"Nat. Genet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/hep.24017","article-title":"Genetic variation in the PNPLA3 gene is associated with alcoholic liver injury in caucasians","volume":"53","author":"Stickel","year":"2011","journal-title":"Hepatology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jhep.2011.01.028","article-title":"Common polymorphism in the PNPLA3\/adiponutrin gene confers higher risk of cirrhosis and liver damage in alcoholic liver disease","volume":"55","author":"Gustot","year":"2011","journal-title":"J. Hepatol"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hep.24350","article-title":"Impact of patatin-like phospholipase-3 (rs738409 C > G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C","volume":"54","author":"Pradat","year":"2011","journal-title":"Hepatology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.25634","article-title":"I148M PNPLA3 variant and progressive liver disease: A new paradigm in hepatology","volume":"56","author":"Valenti","year":"2012","journal-title":"Hepatology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e27087","DOI":"10.1371\/journal.pone.0027087","article-title":"The PNPLA3 rs738409 148M\/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis","volume":"6","author":"Nischalke","year":"2011","journal-title":"PLoS One"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/hep.24123","article-title":"Patatin-like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C","volume":"53","author":"Valenti","year":"2011","journal-title":"Hepatology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1478-3231.2011.02534.x","article-title":"PNPLA3 rs738409C\/G polymorphism in cirrhosis: Relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence","volume":"31","author":"Falleti","year":"2011","journal-title":"Liver Int"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.dld.2012.05.006","article-title":"PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals","volume":"44","author":"Burza","year":"2012","journal-title":"Dig. Liver Dis"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Hassan, M.M., Kaseb, A., Etzel, C.J., El-Serag, H., Spitz, M.R., Chang, P., Hale, K.S., Liu, M., Rashid, A., and Shama, M. (2013). Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction. Mol. Carcinog.","DOI":"10.1002\/mc.22057"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease","volume":"53","author":"Sookoian","year":"2011","journal-title":"Hepatology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bpg.2011.02.007","article-title":"Genetics and epigenetics in the fibrogenic evolution of chronic liver diseases","volume":"25","author":"Zimmer","year":"2011","journal-title":"Best. Pract. Res. Clin. Gastroenterol"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","article-title":"Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase","volume":"15","author":"Kumari","year":"2012","journal-title":"Cell Metab"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4669","DOI":"10.1093\/hmg\/ddp424","article-title":"Genetic evidence for a role of adiponutrin in the metabolism of apolipoprotein B-containing lipoproteins","volume":"18","author":"Kollerits","year":"2009","journal-title":"Hum. Mol. Genet"},{"key":"ref_27","first-page":"369","article-title":"The common adiponutrin variant p.I148M does not confer gallstone risk but affects fasting glucose and triglyceride levels","volume":"62","author":"Krawczyk","year":"2011","journal-title":"J. Physiol. Pharmacol"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e39362","DOI":"10.1371\/journal.pone.0039362","article-title":"Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant","volume":"7","author":"Palmer","year":"2012","journal-title":"PLoS One"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.jhep.2012.07.030","article-title":"Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro","volume":"57","author":"Pirazzi","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nm0511-552","article-title":"Scraping fibrosis: Expressway to the core of fibrosis","volume":"17","author":"Mehal","year":"2011","journal-title":"Nat. Med"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1073\/pnas.1003585107","article-title":"A feed-forward loop amplifies nutritional regulation of PNPLA3","volume":"107","author":"Huang","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2010.10.024","article-title":"Distinct regulation of adiponutrin\/PNPLA3 gene expression by the transcription factors ChREBP and SREBP1c in mouse and human hepatocytes","volume":"55","author":"Dubuquoy","year":"2011","journal-title":"J. Hepatol"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: Regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI2961","article-title":"Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2","volume":"101","author":"Horton","year":"1998","journal-title":"J. Clin. Invest"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1172\/JCI118951","article-title":"Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a","volume":"98","author":"Shimano","year":"1996","journal-title":"J. Clin. Invest"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.cmet.2011.02.004","article-title":"Regulation of lipid homeostasis by the bifunctional SREBF2-miR33a locus","volume":"13","author":"Bommer","year":"2011","journal-title":"Cell Metable"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0888-7543(95)80009-B","article-title":"Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13","volume":"25","author":"Hua","year":"1995","journal-title":"Genomics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.diabres.2008.06.017","article-title":"Association of sterol regulatory element-binding protein-1c gene polymorphism with type 2 diabetes mellitus, insulin resistance and blood lipid levels in Chinese population","volume":"82","author":"Liu","year":"2008","journal-title":"Diabetes Res. Clin. Pract"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1007\/s00125-006-0430-1","article-title":"Polymorphisms in the gene encoding sterol regulatory element-binding factor-1c are associated with type 2 diabetes","volume":"49","author":"Harding","year":"2006","journal-title":"Diabetologia"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"842","DOI":"10.2337\/diabetes.53.3.842","article-title":"Genetic variants in human sterol regulatory element binding protein-1c in syndromes of severe insulin resistance and type 2 diabetes","volume":"53","author":"Laudes","year":"2004","journal-title":"Diabetes"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/sj.ijo.0803505","article-title":"The SREBF-1 locus is associated with type 2 diabetes and plasma adiponectin levels in a middle-aged Austrian population","volume":"31","author":"Felder","year":"2007","journal-title":"Int. J. Obes"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1053\/j.gastro.2008.01.034","article-title":"Performance of transient elastography for the staging of liver fibrosis: A meta-analysis","volume":"134","author":"Ong","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/hep.21847","article-title":"Increased gallstone risk in humans conferred by common variant of hepatic ATP-binding cassette transporter for cholesterol","volume":"46","author":"Acalovschi","year":"2007","journal-title":"Hepatology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nrg2918","article-title":"Network medicine: A network-based approach to human disease","volume":"12","author":"Gulbahce","year":"2011","journal-title":"Nat. Rev. Genet"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"C47","DOI":"10.1038\/35011540","article-title":"From molecular to modular cell biology","volume":"402","author":"Hartwell","year":"1999","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"30028","DOI":"10.1074\/jbc.274.42.30028","article-title":"Increased levels of nuclear SREBP-1c associated with fatty livers in two mouse models of diabetes mellitus","volume":"274","author":"Shimomura","year":"1999","journal-title":"J. Biol. Chem"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e31812","DOI":"10.1371\/journal.pone.0031812","article-title":"Liver-specific expression of transcriptionally active sREBP-1c is associated with fatty liver and increased visceral fat mass","volume":"7","author":"Knebel","year":"2012","journal-title":"PLoS One"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1111\/j.1872-034X.2008.00382.x","article-title":"Liver X receptor in cooperation with SREBP-1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease","volume":"38","author":"Higuchi","year":"2008","journal-title":"Hepatol. Res"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cmet.2011.12.017","article-title":"The scap\/SREBP pathway is essential for developing diabetic fatty liver and carbohydrate-induced hypertriglyceridemia in animals","volume":"15","author":"Moon","year":"2012","journal-title":"Cell Metab"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: Diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/10\/21153\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T21:50:04Z","timestamp":1760219404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/14\/10\/21153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,22]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10]]}},"alternative-id":["ijms141021153"],"URL":"https:\/\/doi.org\/10.3390\/ijms141021153","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2013,10,22]]}}}